Government faces price cut dilemma

Now, the government faces a “dilemma’’ over whether to cut prices of pharmaceutical products through the so-called positive list system to evaluate the cost effectiveness of medicines, as the unilateral move might invite strong protest and criticism from the industry.

“The government needs to review the impact of price reduction on medicines as a number of pharmaceutical firms have raised de...